NCT06695156

Brief Summary

This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 28, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 2, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 19, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

November 6, 2025

Status Verified

August 1, 2025

Enrollment Period

1.7 years

First QC Date

November 2, 2024

Last Update Submit

November 5, 2025

Conditions

Keywords

MigraineMeditationTranscendental Meditation

Outcome Measures

Primary Outcomes (4)

  • Frequency and functionality

    Frequency and functionality will be measured by the data recorded in the migraine App.

    6 Months

  • The Migraine Disability Assessment (MIDAS) to measure frequency and functionality.

    6 Months

  • Migraine Specific Quality of Life Questionnaire (MSQ), version 2.1 to measure impact on Quality of Life

    6 Months

  • Questionnaire (MSQ), version 2.1 to measure impact on functionality.

    6 months

Study Arms (1)

Exploring the Effect of the Transcendental Meditation® Technique on Migraine

EXPERIMENTAL
Behavioral: Meditation

Interventions

MeditationBEHAVIORAL

The objective of this study is to assess the safety, feasibility, and effects of the practice of the Transcendental Meditation technique in adults with migraines. This study will involve 30 male and female participants recruited from migraine treatment facilities and migraine support groups in the US. The study will span three months, with all participants practicing Transcendental Meditation (TM) while continuing their usual lifestyle and medication regimen. Pre-data will be collected through symptom analysis, headache patterns, and evaluation questionnaires. All potential subjects will use a migraine App for 30 days prior to inclusion in the study, both as a means of assessing migraine status and of ability to adhere to study protocols during the study. In addition, all subjects will take the PHQ-9 to screen for levels of depression that might impair participation in the study. All the subjects will receive TM instruction, followed by bi-weekly

Exploring the Effect of the Transcendental Meditation® Technique on Migraine

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of migraine with or without aura, based on ICHD3 criteria
  • migraine days/month.
  • ≥ one-year history of migraines starting before the age of 50.
  • ≥ 18 years old or ≤ 60 Years old
  • Willing to attend follow-up sessions.
  • Willing to practice TM twice a day for 20 minutes.
  • Fluent in English.
  • Willing to continue the same medication without any additional medicine
  • In good general health, with no other diseases expected to interfere with the study.

You may not qualify if:

  • \> 60 years old or \< 18 Years old
  • Already practicing Transcendental Meditation.
  • Pre-diagnosed major systemic illness or unstable medical/psychiatric condition (eg, suicide risk) requiring immediate treatment or that could compromise protocol adherence
  • Medication overuse headache (MOH)
  • Current/planned pregnancy or breastfeeding
  • New prophylactic migraine medicine started within 4 weeks of the screening visit
  • Unwilling to maintain stable migraine medication dosages
  • Failure to complete baseline headache logs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Georgetown Headache Center and DC area

Washington D.C., District of Columbia, 20036, United States

Location

Related Links

MeSH Terms

Conditions

Migraine Disorders

Interventions

Meditation

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Dr. Fred T Travis, PhD

    Maharishi International University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: It is a pilot study investigating the impact of Transcendental Meditation on migraine as a basis for a larger randomized control study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Brain Center and PhD Chair of the Department of Maharishi Vedic Science at Maharishi University of Management

Study Record Dates

First Submitted

November 2, 2024

First Posted

November 19, 2024

Study Start

August 28, 2024

Primary Completion

April 30, 2026

Study Completion

May 1, 2026

Last Updated

November 6, 2025

Record last verified: 2025-08

Locations